Prolia® (denosumab) is a prescription medication used to treat osteoporosis in postmenopausal women and men who are at high risk for fractures. It’s also used to treat bone loss caused by certain cancer treatments. Prolia works by slowing bone breakdown, helping to increase bone strength and reduce the risk of fractures. Administered as a subcutaneous injection once every six months, it offers a convenient and effective option for long-term bone health management.